Edition:
United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

64.47EUR
11:35am EDT
Change (% chg)

€-0.12 (-0.19%)
Prev Close
€64.59
Open
€65.00
Day's High
€65.10
Day's Low
€63.50
Volume
1,385,102
Avg. Vol
1,331,164
52-wk High
€70.00
52-wk Low
€52.09

FREG.DE

Chart for FREG.DE

About

Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments... (more)

Overall

Beta: 0.50
Market Cap(Mil.): €35,263.60
Shares Outstanding(Mil.): 545.96
Dividend: 0.55
Yield (%): 0.85

Financials

  FREG.DE Industry Sector
P/E (TTM): 25.68 51.36 44.92
EPS (TTM): 2.51 -- --
ROI: 8.51 6.14 12.47
ROE: 13.41 9.61 13.34
Search Stocks

BRIEF-Fresenius SE says Loew-Friedrich, Stars to be appointed to board

* Says Roland Berger, Gerhard Roggemann to quit supervisory board

Mar 11 2016

BRIEF-Fresenius says Gerd Krick to run again for supervisory board chairman

* If elected to the supervisory board, Gerd Krick will be proposed for election as chairman Further company coverage:

Mar 11 2016

Fresenius eyes 8-12 pct profit growth on hospitals, dialysis

FRANKFURT, Feb 24 Fresenius SE said on Wednesday it aimed to increase 2016 net income by 8 to 12 percent, adjusted for currency swings and one-off items, driven by growth at its German hospital chain, kidney dialysis operations and its hospital development business.

Feb 24 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Finlabo SIM Spa
$10.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$169.00
Provider : Wright Reports
$169.00
Provider : MarketLine
$50.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks